The cosmetics giant has announced the signing of an agreement to acquire Takami Co., a Japanese company specializing in premium skincare.
This company develops and markets products licensed by the skincare brand Takami, owned by Doctor Hiroshi Takami, founder of two eponymous dermatological and aesthetic clinics established in the Omotesando district of Tokyo.
Strong reputation in Japan and China
Founded in 1999, Takami is a premium skincare brand, expert in peeling. The brand is particularly famous for its iconic product, the Skin Peel pre-serum, also called the "Little Blue Bottle" by Asian women.
Mainly available in Japan and in some Asian countries, notably in China where it enjoys strong appeal, the brand is marketed through an omnichannel distribution: mostly in e-commerce, in particular by subscription, as well as in selective distribution. The brand achieved sales revenue of about 50 million euros in 2019 and continues its growth this year despite difficult market conditions due to Covid-19 impacts.
The transaction, the amount of which has not been disclosed, is expected to be completed in the next few weeks. On this occasion, L’Oréal also renewed a very long term brand licensing agreement with Doctor Takami and signed a collaboration contract with the Takami clinics.
